BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17283127)

  • 41. Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis.
    van Staveren WC; Solís DW; Delys L; Venet D; Cappello M; Andry G; Dumont JE; Libert F; Detours V; Maenhaut C
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):413-8. PubMed ID: 16381821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PTEN, more than the AKT pathway.
    Blanco-Aparicio C; Renner O; Leal JF; Carnero A
    Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways.
    Yeh JJ; Marsh DJ; Zedenius J; Dwight T; Delbridge L; Robinson BG; Eng C
    Genes Chromosomes Cancer; 1999 Dec; 26(4):322-8. PubMed ID: 10534767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of PTEN/PI3K pathway in endothelial cells.
    Suzuki A; Hamada K; Sasaki T; Mak TW; Nakano T
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):172-6. PubMed ID: 17371230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinoma.
    Beg S; Siraj AK; Jehan Z; Prabakaran S; Al-Sobhi SS; Al-Dawish M; Al-Dayel F; Al-Kuraya KS
    Br J Cancer; 2015 Jun; 112(12):1938-43. PubMed ID: 25989274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
    Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
    JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cowden disease and the PTEN gene: a successfully clinical and biological combined approach].
    Longy M
    Bull Cancer; 2001 Dec; 88(12):1153-8. PubMed ID: 11792608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Embryonic epithelial Pten deletion through Nkx2.1-cre leads to thyroid tumorigenesis in a strain-dependent manner.
    Tiozzo C; Danopoulos S; Lavarreda-Pearce M; Baptista S; Varimezova R; Al Alam D; Warburton D; Virender R; De Langhe S; Di Cristofano A; Bellusci S; Minoo P
    Endocr Relat Cancer; 2012 Apr; 19(2):111-122. PubMed ID: 22167068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two distinct thyroid tumours in a patient with Cowden syndrome carrying both a 10q23 and a mitochondrial DNA germline deletion.
    Pradella LM; Zuntini R; Magini P; Ceccarelli C; Neri I; Cerasoli S; Graziano C; Gasparre G; Turchetti D
    J Med Genet; 2011 Nov; 48(11):779-82. PubMed ID: 21926107
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TGF-beta-induced apoptosis in human thyrocytes is mediated by p27kip1 reduction and is overridden in neoplastic thyrocytes by NF-kappaB activation.
    Bravo SB; Pampín S; Cameselle-Teijeiro J; Carneiro C; Domínguez F; Barreiro F; Alvarez CV
    Oncogene; 2003 Oct; 22(49):7819-30. PubMed ID: 14586408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thyroglobulin suppresses thyroid-specific gene expression in cultures of normal but not neoplastic human thyroid follicular cells.
    Ishido Y; Yamazaki K; Kammori M; Sugishita Y; Luo Y; Yamada E; Yamada T; Sellitti DF; Suzuki K
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E694-702. PubMed ID: 24433000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary lung adenocarcinoma occurring in a PTEN related syndrome (Cowden's disease): routine EGFR sequencing also highlights two rare somatic mutations S768I and V769L.
    Boespflug A; Couraud S; Bringuier PP; Isaac S; Gérinière L; Perrot E; Edery P; Durieu I; Souquet PJ
    Lung Cancer; 2013 Mar; 79(3):318-20. PubMed ID: 23261230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A phase II study of TAS-117 in patients with advanced solid tumors harboring germline
    Rodón J; Funchain P; Laetsch TW; Arkenau HT; Hervieu A; Singer CF; Murciano-Goroff YR; Chawla SP; Anthony K; Yamamiya I; Liu M; Halim AB; Benhadji KA; Takahashi O; Delaloge S
    Future Oncol; 2022 Sep; 18(30):3377-3387. PubMed ID: 36039910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors.
    Antico Arciuch VG; Russo MA; Dima M; Kang KS; Dasrath F; Liao XH; Refetoff S; Montagna C; Di Cristofano A
    Oncotarget; 2011 Dec; 2(12):1109-26. PubMed ID: 22190384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome.
    Barletta JA; Bellizzi AM; Hornick JL
    Am J Surg Pathol; 2011 Oct; 35(10):1505-11. PubMed ID: 21921783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
    Fang J; Ding M; Yang L; Liu LZ; Jiang BH
    Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development.
    Tibarewal P; Rathbone V; Constantinou G; Pearce W; Adil M; Varyova Z; Folkes L; Hampson A; Classen GAE; Alves A; Carvalho S; Scudamore CL; Vanhaesebroeck B
    J Pathol; 2022 Dec; 258(4):382-394. PubMed ID: 36073856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PTEN autoregulates its expression by stabilization of p53 in a phosphatase-independent manner.
    Tang Y; Eng C
    Cancer Res; 2006 Jan; 66(2):736-42. PubMed ID: 16424003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.
    Banneau G; Guedj M; MacGrogan G; de Mascarel I; Velasco V; Schiappa R; Bonadona V; David A; Dugast C; Gilbert-Dussardier B; Ingster O; Vabres P; Caux F; de Reynies A; Iggo R; Sevenet N; Bonnet F; Longy M
    Breast Cancer Res; 2010; 12(4):R63. PubMed ID: 20712882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How to recognize Cowden syndrome: A novel PTEN mutation description.
    Delannoy P; Debray FG; Verloes A; Beckers A; Valdes-Socin H
    Ann Endocrinol (Paris); 2017 Jul; 78(3):188-190. PubMed ID: 28262255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.